GuiDeCode

ARISCAT Score for Postoperative Pulmonary Complications

Predicts risk of postoperative pulmonary complications in non-cardiac surgery

Calculator

Loading calculator…

Why use it

Identifies high-risk patients who need intensified respiratory monitoring, prophylactic physiotherapy, and selective use of lung-protective ventilation strategies. PPCs occur in 5–10% of non-cardiac surgeries and increase 30-day mortality 10-fold. ARISCAT is the only PPC risk score externally validated in a large multicenter European cohort.

About

The ARISCAT (Assess Respiratory RIsk in Surgical patients in CATalonia) score is a validated preoperative risk stratification tool for postoperative pulmonary complications (PPC) following non-cardiac surgery. PPCs include respiratory failure, respiratory infections (pneumonia, tracheobronchitis), pleural effusion, atelectasis, pneumothorax, and bronchospasm — and are the leading cause of postoperative morbidity and mortality. The ARISCAT score uses seven independent preoperative predictors (age, preoperative SpO₂, respiratory infection in the past month, preoperative anemia, surgical incision site, duration of surgery, and emergency procedure) to classify patients into three risk groups.

When to use

  • Preoperative risk assessment for any non-cardiac surgery patient
  • Planning perioperative respiratory management (physiotherapy, ventilation strategy, ICU admission)
  • Anesthesia pre-assessment clinics for intermediate and high-risk patients
  • Informed consent discussions about respiratory risks of surgery
  • Research case-mix adjustment for postoperative outcomes

Formula

ARISCAT Score = Sum of the following items: Age: <51 years=0, 51–80 years=+3, >80 years=+16 Preoperative SpO₂ (room air): ≥96%=0, 91–95%=+8, ≤90%=+24 Respiratory infection in last month: No=0, Yes=+17 Preoperative anemia (Hgb ≤10 g/dL): No=0, Yes=+11 Surgical incision site: Peripheral/superficial=0, Upper abdominal=+15, Intrathoracic=+24 Duration of surgery: <2 hours=0, 2–3 hours=+16, >3 hours=+23 Emergency procedure: No=0, Yes=+8 Risk Groups: Low: < 26 → ~1.6% PPC risk Intermediate: 26–44 → ~13.3% PPC risk High: ≥ 45 → ~42.1% PPC risk

Pearls & pitfalls

  • ARISCAT was derived from 2,464 patients across 59 hospitals in Spain (ARISCAT Group, Anesthesiology 2010).
  • SpO₂ < 90% at room air preoperatively scores the highest single weight (+24 points) — always obtain preoperative SpO₂.
  • Intrathoracic surgery carries the highest incision-site score (+24 points), reflecting direct pulmonary manipulation.
  • Duration of surgery > 3 hours doubles PPC risk compared to surgery < 2 hours.
  • Emergency procedures add 8 points, likely due to inadequate preoperative optimization.
  • Preoperative anemia (Hgb ≤ 10 g/dL) is an independent risk factor for PPCs (+11 points).
  • External validation in the PERISCOPE cohort (>6,000 patients, 28 European countries) confirmed ARISCAT performance with AUC 0.72.

Next steps

Low risk (ARISCAT < 26): Routine perioperative care. Intermediate risk (26–44): Intensified respiratory monitoring; consider preoperative physiotherapy; discuss lung-protective intraoperative ventilation. High risk (≥ 45): Highest risk of PPC (42%); consider preoperative optimization; plan ICU admission; mandatory lung-protective ventilation (tidal volume 6–8 mL/kg IBW, PEEP 5–8 cmH₂O); postoperative NIV if needed.

Evidence

Canet J et al. (Anesthesiology 2010) derived ARISCAT from 2,464 patients; PPC incidence 11.6%. AUC 0.90 for in-hospital PPC. Externally validated in PERISCOPE study (Mazo V et al., Anesthesiology 2014): 6,121 patients, 28 countries, AUC 0.72, confirmed three risk strata. Endorsed by the European Society of Anaesthesiology.

References

  1. Canet J et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113(6):1338-1350. — link
  2. Mazo V et al. Prospective external validation of a predictive score for postoperative pulmonary complications. Anesthesiology. 2014;121(2):219-231. — link